North America segment contributes over 35% of global buprenorphine market share
Market Overview: The global buprenorphine market is estimated to be valued at US$ 3,681.9 million in 2022 and is expected to exhibit a CAGR of 14.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Buprenorphine is a partial opioid agonist used to treat opioid addiction and pain. It provides an effective alternative to methadone for...
0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Commandité